M. Ratcliffe

2.5k total citations
47 papers, 1.6k citations indexed

About

M. Ratcliffe is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, M. Ratcliffe has authored 47 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 12 papers in Molecular Biology. Recurrent topics in M. Ratcliffe's work include Cancer Immunotherapy and Biomarkers (16 papers), Lung Cancer Treatments and Mutations (16 papers) and Cancer Genomics and Diagnostics (12 papers). M. Ratcliffe is often cited by papers focused on Cancer Immunotherapy and Biomarkers (16 papers), Lung Cancer Treatments and Mutations (16 papers) and Cancer Genomics and Diagnostics (12 papers). M. Ratcliffe collaborates with scholars based in United Kingdom, United States and Italy. M. Ratcliffe's co-authors include Sergei Y. Sokol, Keiji Itoh, Jill Walker, Craig Barker, Marietta Scott, Nicola Normanno, Martin Reck, Paul Scorer, Marlon C. Rebelatto and James M. Staddon and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

M. Ratcliffe

44 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Ratcliffe United Kingdom 20 680 661 619 411 198 47 1.6k
Chee Wai Chua Hong Kong 18 741 1.1× 484 0.7× 1.0k 1.7× 406 1.0× 98 0.5× 29 1.6k
Chee Wee Ong Singapore 21 688 1.0× 314 0.5× 845 1.4× 338 0.8× 179 0.9× 35 1.5k
Roxanne Toivanen Australia 15 558 0.8× 937 1.4× 597 1.0× 374 0.9× 140 0.7× 21 1.5k
Armelle Degeorges France 18 776 1.1× 404 0.6× 747 1.2× 562 1.4× 117 0.6× 34 1.6k
Dai Shimizu Japan 25 560 0.8× 545 0.8× 980 1.6× 349 0.8× 196 1.0× 136 1.8k
Karsten Gravdal Norway 16 465 0.7× 354 0.5× 620 1.0× 330 0.8× 133 0.7× 28 1.2k
Celina M. D’Cruz United States 16 688 1.0× 493 0.7× 1.1k 1.7× 299 0.7× 96 0.5× 38 1.8k
Yajun Yi United States 22 389 0.6× 320 0.5× 969 1.6× 490 1.2× 247 1.2× 31 1.7k
Satoshi Hayama Japan 16 400 0.6× 376 0.6× 1.1k 1.7× 258 0.6× 119 0.6× 31 1.6k

Countries citing papers authored by M. Ratcliffe

Since Specialization
Citations

This map shows the geographic impact of M. Ratcliffe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Ratcliffe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Ratcliffe more than expected).

Fields of papers citing papers by M. Ratcliffe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Ratcliffe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Ratcliffe. The network helps show where M. Ratcliffe may publish in the future.

Co-authorship network of co-authors of M. Ratcliffe

This figure shows the co-authorship network connecting the top 25 collaborators of M. Ratcliffe. A scholar is included among the top collaborators of M. Ratcliffe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Ratcliffe. M. Ratcliffe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Zając, M, Marietta Scott, M. Ratcliffe, et al.. (2019). Concordance among four commercially available, validated programmed cell death ligand-1 assays in urothelial carcinoma. Diagnostic Pathology. 14(1). 99–99. 38 indexed citations
4.
Scott, Marietta, M. Ratcliffe, Catherine Wadsworth, et al.. (2018). MA19.02 Prior Therapy and Increased Expression of PD-L1 in NSCLC Tumor Samples. Journal of Thoracic Oncology. 13(10). S422–S422.
5.
Scott, Marietta, Sophie Wildsmith, M. Ratcliffe, et al.. (2018). Comparison of patient populations identified by different PD-L1 assays in head and neck squamous cell carcinoma (HNSCC). Annals of Oncology. 29. viii375–viii375. 9 indexed citations
6.
Ratcliffe, M., Alan Sharpe, Anita Midha, et al.. (2017). Agreement between Programmed Cell Death Ligand-1 Diagnostic Assays across Multiple Protein Expression Cutoffs in Non–Small Cell Lung Cancer. Clinical Cancer Research. 23(14). 3585–3591. 237 indexed citations
7.
Han, Baohui, Sergei Tjulandin, Koichi Hagiwara, et al.. (2017). EGFR mutation prevalence in Asia-Pacific and Russian patients with advanced NSCLC of adenocarcinoma and non-adenocarcinoma histology: The IGNITE study. Lung Cancer. 113. 37–44. 113 indexed citations
8.
Normanno, Nicola, Heather A. Brown, Vincent Haddad, et al.. (2016). 580_PR: Clinical and demographic features that influence EGFR mutation detection in plasma from patients (pts) with aNSCLC: The ASSESS experience. Journal of Thoracic Oncology. 11(4). S151–S151. 4 indexed citations
9.
10.
11.
Sherwood, James, Simon Dearden, M. Ratcliffe, & Jill Walker. (2015). Mutation status concordance between primary lesions and metastatic sites of advanced non-small-cell lung cancer and the impact of mutation testing methodologies: a literature review. Journal of Experimental & Clinical Cancer Research. 34(1). 92–92. 49 indexed citations
12.
Ratcliffe, M. & Iain G. Dougall. (2012). Comparison of the anti-inflammatory effects of Cilomilast, Budesonide and a p38 Mitogen activated protein kinase inhibitor in COPD lung tissue macrophages. BMC Pharmacology and Toxicology. 13(1). 15–15. 14 indexed citations
13.
Luckhurst, Christopher A., M. Ratcliffe, Mark Furber, et al.. (2010). Synthesis and biological evaluation of N-alkylated 8-oxybenz[c]azepine derivatives as selective PPARδ agonists. Bioorganic & Medicinal Chemistry Letters. 21(1). 531–536. 10 indexed citations
14.
Doyle, Ian, M. Ratcliffe, Andrew Walding, et al.. (2009). Differential gene expression analysis in human monocyte-derived macrophages: Impact of cigarette smoke on host defence. Molecular Immunology. 47(5). 1058–1065. 28 indexed citations
15.
Itoh, Keiji, Barbara K. Brott, Gyu‐Un Bae, M. Ratcliffe, & Sergei Y. Sokol. (2005). Nuclear localization is required for Dishevelled function in Wnt/β-catenin signaling. Journal of Biology. 4(1). 3–3. 186 indexed citations
16.
Ratcliffe, M., Keiji Itoh, & Sergei Y. Sokol. (2000). A Positive Role for the PP2A Catalytic Subunit in Wnt Signal Transduction. Journal of Biological Chemistry. 275(46). 35680–35683. 89 indexed citations
17.
Ratcliffe, M., Caroline Smales, & James M. Staddon. (1999). Dephosphorylation of the catenins p120 and p100 in endothelial cells in response to inflammatory stimuli. Biochemical Journal. 338(2). 471–471. 9 indexed citations
18.
Ratcliffe, M.. (1998). Pluto - the ninth planet. Journal of the British Astronomical Association. 108. 294. 1 indexed citations
19.
Staddon, James M., M. Ratcliffe, Louise Morgan, et al.. (1997). Protein phosphorylation and the regulation of cell-cell junctions in brain endothelial cells.. PubMed. Suppl 12. 106–9. 11 indexed citations
20.
Ratcliffe, M., et al.. (1989). Clinical trial reporting the need for adequate planning and progress monitoring. 4(2). 131–137. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chee Wai Chua Breakdown of academic impact, for papers by Chee Wee Ong Breakdown of academic impact, for papers by Roxanne Toivanen Breakdown of academic impact, for papers by Armelle Degeorges Breakdown of academic impact, for papers by Dai Shimizu Breakdown of academic impact, for papers by Karsten Gravdal Breakdown of academic impact, for papers by Celina M. D’Cruz Breakdown of academic impact, for papers by Yajun Yi Breakdown of academic impact, for papers by Satoshi Hayama
Rankless by CCL
2026